Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
US5958940A · kind A · utility
25Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 1997 |
| Grant date | Sep 28, 1999 |
| Priority date | — |
| Expiry date | Sep 11, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel tricyclic compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel tricyclic compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammals such as a human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.